Butterfly Ayurveda appoints Anjali Pattanayak as Company Secretary

Butterfly Ayurveda Private Limited, a material subsidiary of Sai Capital , appointed Ms. Anjali Pattanayak as Company Secretary and Key Managerial Personnel effective May 28, 2026. The appointment was approved by the board of directors of the subsidiary at a meeting held on the same day. This move strengthens the subsidiary's compliance and governance framework.

The appointment was intimated to the stock exchanges under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure references the SEBI Master Circular dated January 30, 2026.

Ms. Anjali Pattanayak is an Associate Member of the Institute of Company Secretaries of India (ICSI), holding membership number A75339. Her professional experience includes expertise in Secretarial Affairs, Corporate Governance, and Statutory Compliances.

Appointment Details

The specific details of the appointment are outlined below:

S. No	Particulars	Information
1.	Reason for change	Appointment of Ms. Anjali Pattanayak as Company Secretary (Key Managerial Personnel) of Butterfly Ayurveda Private Limited
2.	Date of appointment	May 28, 2026
3.	Term of appointment	Not Applicable
4.	Brief Profile	Associate Member of ICSI with experience in Secretarial Affairs, Corporate Governance, & Statutory Compliances

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.60%	-4.85%	-3.93%	-28.98%	-34.58%	+788.76%

Sai Capital reported a consolidated net profit of ₹1,255.69 lakh for the financial year ended March 31, 2026, driven by its subsidiaries, while its standalone operations recorded a loss of ₹68.23 lakh for the same period. The company’s Board of Directors approved the audited financial results for the fourth quarter and financial year on May 26, 2026. Statutory auditors M/s. Mehrotra & Co. issued an unmodified opinion on both the standalone and consolidated financial results.

The standalone financial performance reflects continued operational challenges with zero revenue from operations and total expenses of ₹68.23 lakh for the year. The statutory auditors highlighted a material uncertainty regarding the company’s ability to continue as a going concern due to eroded net worth and cash losses from operations. Management stated plans to meet financial obligations through cash flows from future plans and subsidiaries.

In contrast, the consolidated results, which include subsidiaries such as Healthcare Energy Foods Private Limited, Unisphere Industries Private Limited, and Butterfly Ayurveda Private Limited, showed a total income of ₹2,453.57 lakh for FY26. Profit before tax for the consolidated entity stood at ₹1,825.56 lakh, with basic earnings per share (EPS) increasing to ₹43.61 from ₹37.64 in the previous year.

Financial Results Summary

Metric	Standalone FY26 (Amount in ₹ Lacs)	Consolidated FY26 (Amount in ₹ Lacs)
Total Income	0.00	2,453.57
Total Expenses	68.23	628.01
Profit for the Period	(68.23)	1,255.69
Basic EPS	(2.37)	43.61

Board Decisions and Auditor Appointments

The Board approved the re-appointment of M/s. Gurkaran Singh & Co. as internal auditors for the financial year 2026-27 based on the Audit Committee's recommendation. The meeting, held on May 26, 2026, also reviewed and took on record the financial results. The statutory auditors confirmed compliance with Indian Accounting Standards and SEBI Listing Regulations in their report.

Pursuant to Regulation 30 read with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company published the Quick Response Code and website link to access the audited financial results in the Delhi editions of the Financial Express and Jansatta on May 27, 2026.